The perivascular microenvironment in Epstein–Barr virus positive primary central nervous system lymphoma: The role of programmed cell death 1 and programmed cell death ligand 1. Issue 2 (24th October 2017)
- Record Type:
- Journal Article
- Title:
- The perivascular microenvironment in Epstein–Barr virus positive primary central nervous system lymphoma: The role of programmed cell death 1 and programmed cell death ligand 1. Issue 2 (24th October 2017)
- Main Title:
- The perivascular microenvironment in Epstein–Barr virus positive primary central nervous system lymphoma: The role of programmed cell death 1 and programmed cell death ligand 1
- Authors:
- Sugita, Yasuo
Furuta, Takuya
Ohshima, Koichi
Komaki, Satoru
Miyoshi, Junko
Morioka, Motohiro
Abe, Hideyuki
Nozawa, Takanori
Fujii, Yukihiko
Takahashi, Hitoshi
Kakita, Akiyoshi - Abstract:
- Abstract : It has been shown that high expression of certain immune checkpoint molecules, including those of the programmed death protein 1/programmed death ligand 1 (PD‐1/PD‐L1) axis, can be utilized to regulate immunosuppression in the microenvironment of malignant neoplasms. For the purpose of clarifying the immune‐escape mechanism of primary central nervous system lymphomas (PCNSLs), particularly in Epstein–Barr virus (EBV)‐positive cases, markers for PD‐1, PD‐L1, tumor‐associated macrophages (TAMs), and tumor‐infiltrating lymphocytes (TILs) in 39 surgical specimens of PCNSLs (17 EBV‐positive, 22 EBV‐negative) were investigated by immunohistochemistry. Staining for PD‐L1 was scored as follows: (−), no staining; (1+), 0–30% positive cells; (2+), 30–60% positive cells; and (3+), >60% positive cells. In EBV‐positive cases, PD‐L1 was detected in both lymphoma cells and TAMs in 12/17 cases, and in TAMs only in 4/17 cases. The mean number of PD‐1, TIA‐1 (a marker for cytotoxic T‐cells), and FOXP3 (a marker for regulatory T‐cells)‐positive TILs in EBV‐positive cases was 36.4 ± 45.9, 390 ± 603, and 9.88 ± 15.1, respectively. In EBV‐negative cases, PD‐L1 was detected in both lymphoma cells and TAMs in 11/22 cases, and in TAMs only in 4/22 cases. The mean of PD‐1, TIA‐1 and FOXP3‐positive lymphocytes in EBV‐negative cases was 67.3 ± 82.0, 158 ± 206 and 9.32 ± 17.5, respectively. We found no significant difference in the number of FOXP3‐positive, lymphocytes between EBV‐positiveAbstract : It has been shown that high expression of certain immune checkpoint molecules, including those of the programmed death protein 1/programmed death ligand 1 (PD‐1/PD‐L1) axis, can be utilized to regulate immunosuppression in the microenvironment of malignant neoplasms. For the purpose of clarifying the immune‐escape mechanism of primary central nervous system lymphomas (PCNSLs), particularly in Epstein–Barr virus (EBV)‐positive cases, markers for PD‐1, PD‐L1, tumor‐associated macrophages (TAMs), and tumor‐infiltrating lymphocytes (TILs) in 39 surgical specimens of PCNSLs (17 EBV‐positive, 22 EBV‐negative) were investigated by immunohistochemistry. Staining for PD‐L1 was scored as follows: (−), no staining; (1+), 0–30% positive cells; (2+), 30–60% positive cells; and (3+), >60% positive cells. In EBV‐positive cases, PD‐L1 was detected in both lymphoma cells and TAMs in 12/17 cases, and in TAMs only in 4/17 cases. The mean number of PD‐1, TIA‐1 (a marker for cytotoxic T‐cells), and FOXP3 (a marker for regulatory T‐cells)‐positive TILs in EBV‐positive cases was 36.4 ± 45.9, 390 ± 603, and 9.88 ± 15.1, respectively. In EBV‐negative cases, PD‐L1 was detected in both lymphoma cells and TAMs in 11/22 cases, and in TAMs only in 4/22 cases. The mean of PD‐1, TIA‐1 and FOXP3‐positive lymphocytes in EBV‐negative cases was 67.3 ± 82.0, 158 ± 206 and 9.32 ± 17.5, respectively. We found no significant difference in the number of FOXP3‐positive, lymphocytes between EBV‐positive and negative cases. However, there were significantly higher numbers of PD‐1‐positive lymphocytes in the former, and significantly higher numbers of TIA‐1‐positive lymphocytes in the latter ( P < 0.05). The combined data indicate that expression of PD‐L1 by lymphoma cells and TAMs mediate the trafficking of TILs, which may explain the immune‐escape process of PCNSLs. In addition, EBV infection appears to affect the trafficking mechanism of TILs, and may thus play an important role in the microenvironment immunity of these tumors. … (more)
- Is Part Of:
- Neuropathology. Volume 38:Issue 2(2018)
- Journal:
- Neuropathology
- Issue:
- Volume 38:Issue 2(2018)
- Issue Display:
- Volume 38, Issue 2 (2018)
- Year:
- 2018
- Volume:
- 38
- Issue:
- 2
- Issue Sort Value:
- 2018-0038-0002-0000
- Page Start:
- 125
- Page End:
- 134
- Publication Date:
- 2017-10-24
- Subjects:
- Epstein–Barr virus -- immune escape -- PD‐1 -- PD‐L1 -- primary central nervous system lymphoma
Nervous system -- Diseases -- Periodicals
Nervous system -- Pathophysiology -- Periodicals
616.8047 - Journal URLs:
- http://www.blackwell-synergy.com/member/institutions/issuelist.asp?journal=neu ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1111/neup.12435 ↗
- Languages:
- English
- ISSNs:
- 0919-6544
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 6081.513800
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 5969.xml